Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Wave Life Sciences (WVE) Asset Utilization Ratio (2016 - 2026)

Wave Life Sciences (WVE) has disclosed Asset Utilization Ratio for 12 consecutive years, with 0.08 as the latest value for Q1 2026.

  • For Q1 2026, Asset Utilization Ratio fell 89.22% year-over-year to 0.08; the TTM value through Mar 2026 reached 0.08, down 89.22%, while the annual FY2025 figure was 0.09, 75.03% down from the prior year.
  • Asset Utilization Ratio hit 0.08 in Q1 2026 for Wave Life Sciences, up from 0.04 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.94 in Q2 2024 and bottomed at 0.04 in Q4 2025.
  • Average Asset Utilization Ratio over 5 years is 0.6, with a median of 0.63 recorded in 2022.
  • Year-over-year, Asset Utilization Ratio soared 281.08% in 2022 and then tumbled 93.77% in 2025.
  • Wave Life Sciences' Asset Utilization Ratio stood at 0.51 in 2022, then surged by 75.45% to 0.89 in 2023, then decreased by 27.12% to 0.65 in 2024, then crashed by 93.77% to 0.04 in 2025, then skyrocketed by 89.11% to 0.08 in 2026.
  • According to Business Quant data, Asset Utilization Ratio over the past three periods came in at 0.08, 0.04, and 0.88 for Q1 2026, Q4 2025, and Q3 2025 respectively.